Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nathaniel Weygant Parthasarathy Chandrakesan William L Berry Ralf Janknecht Courtney W Houchen Sripathi Sureban |
| Publication date | May 6, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |